Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1996 1
1998 1
1999 2
2000 2
2001 7
2002 13
2003 8
2004 17
2005 26
2006 33
2007 45
2008 15
2009 20
2010 21
2011 24
2012 14
2013 16
2014 30
2015 40
2016 21
2017 29
2018 23
2019 30
2020 31
2021 31
2022 32
2023 30
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

502 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
van der Heijden MS, Sonpavde G, Powles T, Necchi A, Burotto M, Schenker M, Sade JP, Bamias A, Beuzeboc P, Bedke J, Oldenburg J, Chatta G, Ürün Y, Ye D, He Z, Valderrama BP, Ku JH, Tomita Y, Filian J, Wang L, Purcea D, Patel MY, Nasroulah F, Galsky MD; CheckMate 901 Trial Investigators. van der Heijden MS, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 9;389(19):1778-1789. doi: 10.1056/NEJMoa2309863. Epub 2023 Oct 22. N Engl J Med. 2023. PMID: 37870949 Clinical Trial.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
Creation of bladder assembloids mimicking tissue regeneration and cancer.
Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH, Lee HR, Kim S, Kim HM, Lee H, Yang C, Lee YJ, Kang M, Roh TY, Jung S, Kim S, Ku JH, Shin K. Kim E, et al. Among authors: ku jh. Nature. 2020 Dec;588(7839):664-669. doi: 10.1038/s41586-020-3034-x. Epub 2020 Dec 16. Nature. 2020. PMID: 33328632
Authors' response.
Kim S, Lee NK, Park JH, Ku JH, Kim Y, Kook YA, Kuo Chou AH, Vaid NR. Kim S, et al. Among authors: ku jh. Am J Orthod Dentofacial Orthop. 2023 Feb;163(2):145. doi: 10.1016/j.ajodo.2022.11.010. Am J Orthod Dentofacial Orthop. 2023. PMID: 36710059 No abstract available.
Editorial: Tumor microenvironment in bladder cancer.
Kusmartsev S, Ku JH, Grizzi F. Kusmartsev S, et al. Among authors: ku jh. Front Oncol. 2023 May 3;13:1208196. doi: 10.3389/fonc.2023.1208196. eCollection 2023. Front Oncol. 2023. PMID: 37207141 Free PMC article. No abstract available.
COVID-19 pandemic management and the rheumatology patient.
Varley CD, Ku JH, Winthrop KL. Varley CD, et al. Among authors: ku jh. Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101663. doi: 10.1016/j.berh.2021.101663. Epub 2021 Jan 13. Best Pract Res Clin Rheumatol. 2021. PMID: 33536145 Free PMC article. Review.
Current status of the focused series "Urothelial Carcinoma".
Yuk HD, Kim HS, Ku JH. Yuk HD, et al. Among authors: ku jh. Transl Cancer Res. 2020 Oct;9(10):6534-6536. doi: 10.21037/tcr-2020-uc-10. Transl Cancer Res. 2020. PMID: 35117262 Free PMC article. No abstract available.
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.
502 results